The Cancer Genome Computational Analysis (CGCA) group — a central component of the ӳý’s Cancer Program — addresses unanswered questions of cancer biology and genomics through the development of computational methods and tools, in conjunction with platforms, datasets and resources. Specifically, the group works to understand cancer by characterizing and interpreting genomic data:
CGCA works closely with many groups within the ӳý, including the institute’s Genomics, Genetic Perturbation, and Data Sciences platforms. CGCA members also engage with collaborators from the ӳý’s partner institutions and outside organizations such as IBM. The team also participates in several National Institutes of Health-funded national consortia, such as , the , the , the .
The CGCA team has created a number of powerful genomic analysis tools and platforms for the cancer research community, including:
CGCA has also built and maintains several key genomic data resources, such as:



